Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK3186899 是 Cdc2 相关激酶 12 的抑制剂,对 L. donovani 的 EC50 为 1.4 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,390 | 现货 | ||
5 mg | ¥ 5,780 | 现货 | ||
10 mg | ¥ 7,880 | 现货 | ||
25 mg | ¥ 11,900 | 现货 | ||
50 mg | ¥ 15,900 | 现货 | ||
100 mg | ¥ 21,700 | 现货 |
产品描述 | GSK3186899 is an inhibitor of Cdc2-related kinase 12 with an EC50 of 1.4 μM for L. donovani. |
体外活性 | GSK3186899 is active in cidal axenic amastigote assay with an EC50 value of 0.1 μM. GSK3186899 shows good selectivity against mammalian THP-1 host cells (EC50 value > 50 μM). GSK3186899 exhibits a less than 10-fold variation in potency against a panel of Leishmania-derived lines. GSK3186899 is more active using human peripheral blood mononuclear cells as the host cells[1]. |
体内活性 | In the mouse model of infection, GSK3186899 (25 mg/kg; orally) reduces parasite levels by 99%. The efficacy of treatment is dependent on dose, frequency, and duration (10 days better than 5). There are no notable adverse effects in a rat seven-day repeat-dose oral toxicity study with respect to clinical chemistry and histopathology at all doses tested[1]. |
别名 | 3,3,3-trifluoro-N-[4-[[3-[(2R)-2-methylmorpholin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]amino]cyclohexyl]propane-1-sulfonamide, DDD-853651 |
分子量 | 491.53 |
分子式 | C19H28F3N7O3S |
CAS No. | 1972617-87-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL (406.89 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0345 mL | 10.1723 mL | 20.3446 mL | 50.8616 mL |
5 mM | 0.4069 mL | 2.0345 mL | 4.0689 mL | 10.1723 mL | |
10 mM | 0.2034 mL | 1.0172 mL | 2.0345 mL | 5.0862 mL | |
20 mM | 0.1017 mL | 0.5086 mL | 1.0172 mL | 2.5431 mL | |
50 mM | 0.0407 mL | 0.2034 mL | 0.4069 mL | 1.0172 mL | |
100 mM | 0.0203 mL | 0.1017 mL | 0.2034 mL | 0.5086 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GSK3186899 1972617-87-0 Microbiology/Virology Parasite GSK 3186899 DDD 853651 3,3,3-trifluoro-N-[4-[[3-[(2R)-2-methylmorpholin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]amino]cyclohexyl]propane-1-sulfonamide GSK-3186899 DDD-853651 DDD853651 Inhibitor inhibitor inhibit